Although no major curial appointments or announcements have been made, one person who had a chance to know then-Cardinal ...

In the first month of his pontificate, Pope Leo repeatedly mentioned various themes "that seem to be the initial lines of his ...

In May 2025, a video spread on social media that appeared to show Pope Leo XIV, born Robert Prevost, criticizing U.S. Vice ...

HOUSTON, TX / ACCESS Newswire / May 13, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for ...

HOUSTON - CNS Pharmaceuticals, Inc. (NASDAQ:CNSP), a micro-cap biopharmaceutical company with a market capitalization of $3.56 million, has announced the successful acquisition of Orphan Drug ...

HOUSTON, TX / ACCESS Newswire / May 13, 2025 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for ...

According to recent reports from ESPN NBA insider Shams Charania, the Giannis Antetokounmpo era with the Milwaukee Bucks could be ending. Many teams are expected to do everything possible to ...

The biotechs have been working together in the CNS space since a $1.7 billion biobucks pact in 2019, with their relationship strengthened in 2023 to focus on Voyager’s gene therapy program for ...

LG CNS announced Monday that it has signed a 130 billion won ($88.8 million) deal with Mirae Asset Life Insurance to support the insurer’s artificial intelligence transformation and the ...

The CNS market is expected to exceed $80 billion in sales this year, per GlobalData’s analysis. That would place its year-over-year growth rate at 8%—another high not seen since 2013.

CNS Pharmaceuticals said its Berubicin treatment for an aggressive and usually fatal brain cancer didn't show a statistically significant difference in overall survival during a clinical trial ...

CNS Pharmaceuticals' Berubicin trial for recurrent GBM did not show a significant survival benefit over Lomustine. The study reported no cardiotoxicity with Berubicin, unlike other anthracyclines ...